Secor Capital Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Secor Capital Advisors’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-38,156	Closed	-$1.09M	–	607
2018 Q4	$1.09M	Sell	38,156 -130,860	-77%	-$4.16M	0.14%	207
2018 Q3	$6.62M	Buy	169,016 +63,506	+60%	+$2.35M	0.72%	30
2018 Q2	$3.41M	Sell	105,510 -85,087	-45%	-$2.34M	0.29%	102
2018 Q1	$4.18M	Buy	190,597 +35,514	+23%	+$854K	0.34%	89
2017 Q4	$3.67M	Buy	155,083 +56,341	+57%	+$1.42M	0.15%	109
2017 Q3	$2.78M	Buy	98,742 +62,599	+173%	+$1.9M	0.26%	125
2017 Q2	$1.17M	Sell	36,143 -30,019	-45%	-$915K	0.11%	258
2017 Q1	$1.87M	Buy	+66,162	New	+$1.76M	0.2%	157
2016 Q4	–	Sell	-84,103	Closed	-$2M	–	649
2016 Q3	$2M	Buy	84,103 +57,097	+211%	+$1.25M	0.22%	144
2016 Q2	$496K	Buy	+27,006	New	+$422K	0.06%	403

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Secor Capital Advisors's CSII Position: Q1 2019 in Review

Secor Capital Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2019, closing a stake of 38,156 shares — an estimated $1.09M sold.

Secor Capital Advisors first reported a position in CSII in Q2 2016 and held it in 10 quarters. The position peaked at $6.62M in Q3 2018. 186 funds tracked by Wall St. Rank hold CSII as of Q1 2019.

Secor Capital Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q1 2019 after selling out during the quarter.
Secor Capital Advisors sold 38,156 Cardiovascular Systems, Inc. shares in Q1 2019, an estimated $1.09M.
Secor Capital Advisors first reported a position in Cardiovascular Systems, Inc. in Q2 2016 and held it in 10 quarters.
Secor Capital Advisors's Cardiovascular Systems, Inc. position peaked at $6.62M in Q3 2018.
186 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.